logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Medulloblastoma: intraventricular methotrexate is linked to improved survival

Intraventricular methotrexate can improve poor outcomes with systemic chemotherapy alone.